Eligi
Med
Ensayos clinicos
Suscripcion
Sobre EligiMed
Ensayos Clinicos de Enfermedades Infecciosas | EligiMed
Ensayos clinicos
887 ensayos encontrados
Desconocido
ClinicalTrials.gov
Reduced Frequency Hemodialysis in Prevalent Patients Due to the Coronavirus Disease
OBSERVATIONAL
Inicio: 20 de mar de 2020
ID: NCT04374058
Completado
ClinicalTrials.gov
A Prospective Study of Acute Immune Responses to SARSCoV-2 Infection
OBSERVATIONAL
Inicio: 20 de jul de 2020
ID: NCT04431414
Completado
ClinicalTrials.gov
Biomarker Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
OBSERVATIONAL
Inicio: 22 de abr de 2019
ID: NCT03871816
Completado
Fase 2
ClinicalTrials.gov
A Phase I/II, Multicenter, Open-Label, Noncomparative Study of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Group to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Raltegravir (Isentress, MK-0518) in HIV-1 Infected Children and Adolescents
INTERVENTIONAL
Inicio: 17 de sept de 2007
ID: NCT00485264
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Open Label Study of Safety and Efficacy With BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected With Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV)
INTERVENTIONAL
Inicio: 1 de dic de 2011
ID: NCT01471574
Completado
Fase 3
ClinicalTrials.gov
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
INTERVENTIONAL
Inicio: 4 de feb de 2008
ID: NCT00545532
Completado
ClinicalTrials.gov
Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) in a Vulnerable Neighbourhood, Buenos Aries Argentina
OBSERVATIONAL
Inicio: 10 de jun de 2020
ID: NCT04472078
Terminado
Fase 3
ClinicalTrials.gov
A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus
INTERVENTIONAL
Inicio: 1 de ago de 2007
ID: NCT00496158
Desconocido
ClinicalTrials.gov
Incidence and Implications With the Use of Nasal Cannulas During COVID-19
OBSERVATIONAL
Inicio: 30 de abr de 2020
ID: NCT04376580
Terminado
Fase 4
ClinicalTrials.gov
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Antiretroviral Strategy in Persistently Non-adherent Children, Adolescents, and Young Adults Who Are Failing HAART and Have the M184V Resistance Mutation.
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT01338025
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-Label, Phase III, International Study of Subcutaneous Recombinant IL-2 in Patients With HIV-1 Infection and CD4+ Cell Counts 300/mm^3 or Greater: Evaluation of Subcutaneous Proleukin in a Randomized International Trial
INTERVENTIONAL
Inicio: 1 de mar de 2000
ID: NCT00004978
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and Elderly Non-hospitalized Subjects With Influenza A Infection Who Are at Risk of Developing Complications
INTERVENTIONAL
Inicio: 21 de ene de 2018
ID: NCT03381196
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
INTERVENTIONAL
Inicio: 1 de mar de 2007
ID: NCT00474526
Completado
ClinicalTrials.gov
SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES
OBSERVATIONAL
Inicio: 6 de ago de 2020
ID: NCT04482361
Completado
Fase 3
ClinicalTrials.gov
A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Non-Hospitalized Adults With COVID-19.
INTERVENTIONAL
Inicio: 19 de oct de 2020
ID: NCT04575597
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Controlled, Open Label, Two Arms, Exploratory Study to Evaluate the Effect of Everolimus on Histologically Assessed Fibrosis Progression (Ishak-Knodell) in Liver Transplant Recipients With Recurrent Hepatitis C Viral Infection as Compared to Standard Treatment.
INTERVENTIONAL
Inicio: 1 de dic de 2007
ID: NCT00582738
Terminado
Fase 3
ClinicalTrials.gov
A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
INTERVENTIONAL
Inicio: 1 de ago de 2007
ID: NCT00496002
Activo, no recluta
ClinicalTrials.gov
Estudio Sobre Respuesta de Anticuerpos Neutralizantes Contra la Fiebre Amarilla Cuatro a Siete años después de Vacunar Una población pediátrica Entre Los 12 y 23 Meses de Edad en Argentina
INTERVENTIONAL
Inicio: 6 de dic de 2022
ID: NCT05644145
Completado
Fase 3
ClinicalTrials.gov
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Multi-Center International Randomized Controlled Trial Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumor Resections With Endoprosthetic Replacements
INTERVENTIONAL
Inicio: 1 de ene de 2013
ID: NCT01479283
Activo, no recluta
Fase 3
ClinicalTrials.gov
Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment With Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B Virus (B-Well 1)
INTERVENTIONAL
Inicio: 7 de dic de 2022
ID: NCT05630807
Anterior
1
...
43
44
45
Siguiente
Filtros